by
Lisa Emrich on Multiple Sclerosis
Friday, February 15 2013
When it is quiet in the house, I can practically hear “a pin drop” or the sound of the cats paws walking across the kitchen floor. My hearing is very good. Most of the time.
However, as a musician, I have been exposed to enormously dangerous sound levels during various concert and rehearsal settings. Horn players... Read more
by
Lisa Emrich on Multiple Sclerosis
Wednesday, February 06 2013
Respiratory difficulties are a less common symptom of multiple sclerosis. Problems with breathing may be associated with more advanced disease, however problems can occur at any stage of the disease, even in patients who do not complain of respiratory problems. Just as weakness of leg and hip muscles can affect walking ability,... Read more
by
Lisa Emrich on Multiple Sclerosis
Tuesday, January 29 2013
Amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, is a rapidly progressive motor neuron disease affecting as many as 20,000-30,000 people in the United States. One of the most common neuromuscular diseases worldwide, ALS affects people of all races and ethnic backgrounds, typically between the ages of 40 and 60.... Read more
by
Lisa Emrich on Multiple Sclerosis
Wednesday, January 23 2013
Nicotine may protect against the development of multiple sclerosis, according to researchers from the Institute of Environmental Medicine at the Karolinska Institutet in Sweden. In looking for possible causes and risk factors involved in developing MS, a group of researchers in Sweden have examined several possibilities, including smoking... Read more
by
Lisa Emrich on Multiple Sclerosis
Wednesday, January 09 2013
As of January 2013, the FDA has approved nine disease-modifying drugs or therapies (listed below) for the treatment of relapsing forms of multiple sclerosis, including secondary-progressive MS in patients who still experience relapses. One of the drugs, Novantrone, is specifically approved to treat secondary-progressive MS. Four drugs,... Read more
